Health Catalyst (HCAT) Receivables - Net (2018 - 2026)

Health Catalyst has reported Receivables - Net for 9 years, with the latest figure at $59.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 7.65% year-over-year to $59.1 million; the trailing twelve-month figure through Mar 2026 stood at $59.1 million (down 7.65% YoY), and the FY2025 full-year result was $59.1 million, up 3.4% from the prior year.
• Receivables - Net for Q1 2026 stood at $59.1 million, roughly flat from $59.1 million in the prior quarter.
• The five-year high for Receivables - Net was $68.4 million in Q2 2025, with the low at $42.6 million in Q1 2022.
• Historically, Receivables - Net has averaged $55.1 million across 5 years, with a median of $54.9 million in 2024.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 45.12% — and 2024, when it dropped 12.91%.
• Health Catalyst's Receivables - Net stood at $48.0 million in 2022, then climbed by 25.68% to $60.3 million in 2023, then decreased by 5.16% to $57.2 million in 2024, then advanced by 3.4% to $59.1 million in 2025, then advanced by 0.03% to $59.1 million in 2026.
• The last three Receivables - Net figures came in at $59.1 million (Q1 2026), $59.1 million (Q4 2025), and $60.1 million (Q3 2025), per Business Quant data.